ATE417617T1 - Mittel zur steurung der expression von il-12 - Google Patents
Mittel zur steurung der expression von il-12Info
- Publication number
- ATE417617T1 ATE417617T1 AT02705197T AT02705197T ATE417617T1 AT E417617 T1 ATE417617 T1 AT E417617T1 AT 02705197 T AT02705197 T AT 02705197T AT 02705197 T AT02705197 T AT 02705197T AT E417617 T1 ATE417617 T1 AT E417617T1
- Authority
- AT
- Austria
- Prior art keywords
- expression
- active ingredient
- hyaluronan
- interleukin
- enhancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001074078 | 2001-03-15 | ||
JP2001074077 | 2001-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE417617T1 true ATE417617T1 (de) | 2009-01-15 |
Family
ID=26611324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02705197T ATE417617T1 (de) | 2001-03-15 | 2002-03-14 | Mittel zur steurung der expression von il-12 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20040097465A1 (de) |
EP (1) | EP1369119B1 (de) |
JP (1) | JP4234439B2 (de) |
AT (1) | ATE417617T1 (de) |
CA (1) | CA2440744C (de) |
DE (1) | DE60230388D1 (de) |
WO (1) | WO2002074318A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4673217B2 (ja) * | 2003-04-23 | 2011-04-20 | 由紀夫 佐藤 | メチル化CpGポリヌクレオチド |
HUP0303779A2 (en) * | 2003-11-20 | 2006-02-28 | Richter Gedeon Vegyeszet | Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex |
JP4889206B2 (ja) * | 2004-07-01 | 2012-03-07 | 有限会社 シーバイオン | Il−12産生誘導活性を有するマクロファージ活性化剤 |
JP4528898B2 (ja) * | 2004-07-26 | 2010-08-25 | 独立行政法人科学技術振興機構 | ケモカイン受容体ccr10の発現誘導剤 |
JP4576583B2 (ja) * | 2005-03-22 | 2010-11-10 | キユーピー株式会社 | ヒアルロン酸またはその塩、およびその製造方法、ならびにこれを含有する化粧料および食品組成物 |
US20070099867A1 (en) * | 2005-05-24 | 2007-05-03 | Glycoscience Laboratories, Inc. | Pharmaceutical agent containing hyaluronan as an active ingredient |
JP2009091248A (ja) * | 2006-01-17 | 2009-04-30 | Toshitsu Kagaku Kenkyusho:Kk | 外傷性神経障害および/または運動機能障害の治療薬 |
WO2007099830A1 (ja) | 2006-02-24 | 2007-09-07 | Q.P. Corporation | 新規な低分子ヒアルロン酸および/またはその塩、ならびにこれを用いた化粧料、医薬組成物および食品組成物 |
FR2908658B1 (fr) * | 2006-11-20 | 2011-11-11 | Centre Nat Rech Scient | Composition pour la prevention et/ou le traitement des maladies associees a la surexpression du tnf et/ou de l'il-12 |
US8153614B2 (en) | 2006-12-05 | 2012-04-10 | Glycoscience Laboratories, Inc. | Treatment of osteoarthritis |
JP2008266171A (ja) * | 2007-04-18 | 2008-11-06 | Q P Corp | 自己免疫疾患緩和剤ならびにこれを含有する医薬品および食品 |
MX2010009625A (es) | 2008-03-07 | 2010-09-28 | Acraf | Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40. |
KR101581828B1 (ko) | 2008-03-07 | 2015-12-31 | 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 | 신규한 1-벤질-3-하이드록시메틸인다졸 유도체들 및 mcp-1, cx3cr1 및 p40의 발현을 기초로 한 질환들의 치료에서 이의 용도 |
WO2009113512A1 (ja) * | 2008-03-11 | 2009-09-17 | キユーピー株式会社 | Socs3発現促進剤、これを含有する医薬品および食品、ならびにsocs3の発現を促進する方法 |
JPWO2009113512A1 (ja) * | 2008-03-11 | 2011-07-21 | キユーピー株式会社 | Socs3発現促進剤、これを含有する医薬品および食品、ならびにsocs3の発現を促進する方法 |
FR2931480B1 (fr) * | 2008-05-23 | 2016-04-01 | Centre Nat Rech Scient | Analogues synthetiques de phosphatidyl-myo-inositol mannosides pourvus d'une active inhibitrice de la reponse inflammatoire |
US8462765B2 (en) * | 2008-08-20 | 2013-06-11 | Qualcomm Incorporated | Method and apparatus to perform ranging operations for wireless stations |
EP2545925B1 (de) | 2011-07-12 | 2018-02-14 | Holy Stone Healthcare Co.,Ltd. | Zusammensetzung enthaltend Hyaluronsäure zur Behandlung und Verhinderung von Schleimhauterkrankungen |
CA2871993A1 (en) * | 2012-02-22 | 2013-08-29 | Hyaluronan Research Institute, Inc. | Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active ingredient |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5095037B1 (en) * | 1989-12-21 | 1995-12-19 | Nissho Kk | Combined anti-inflammatory agent |
JP4010574B2 (ja) * | 1994-12-05 | 2007-11-21 | 電気化学工業株式会社 | 皮膚外用剤 |
AU732344B2 (en) * | 1996-01-11 | 2001-04-12 | Jagotec Ag | Oral administration of effective amounts of forms of hyaluronic acid |
-
2002
- 2002-03-14 US US10/471,824 patent/US20040097465A1/en not_active Abandoned
- 2002-03-14 EP EP02705197A patent/EP1369119B1/de not_active Expired - Lifetime
- 2002-03-14 CA CA002440744A patent/CA2440744C/en not_active Expired - Fee Related
- 2002-03-14 DE DE60230388T patent/DE60230388D1/de not_active Expired - Lifetime
- 2002-03-14 JP JP2002573025A patent/JP4234439B2/ja not_active Expired - Fee Related
- 2002-03-14 WO PCT/JP2002/002433 patent/WO2002074318A1/ja active Application Filing
- 2002-03-14 AT AT02705197T patent/ATE417617T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4234439B2 (ja) | 2009-03-04 |
CA2440744A1 (en) | 2002-09-26 |
EP1369119A1 (de) | 2003-12-10 |
US20040097465A1 (en) | 2004-05-20 |
EP1369119B1 (de) | 2008-12-17 |
CA2440744C (en) | 2009-12-08 |
EP1369119A4 (de) | 2004-12-15 |
WO2002074318A1 (fr) | 2002-09-26 |
DE60230388D1 (de) | 2009-01-29 |
JPWO2002074318A1 (ja) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE417617T1 (de) | Mittel zur steurung der expression von il-12 | |
BR9908004A (pt) | Composto, composição e método para prevençãoou supressão de uma infecção viral | |
DE60043587D1 (de) | Mittel für erkrankungen assoziert mit knochensubstanzverlust | |
DE60235083D1 (de) | Substituierte tetracyclin-verbindungen zur behandlung von malaria | |
MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
PT1447399E (pt) | Derivado de 2-oxo-1-pirrolidina e as suas utilizacoes farmaceuticas | |
NO950297D0 (no) | Prolinamidderivater | |
WO2003053359A3 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
CY1107992T1 (el) | Συνθεσεις πολυαμιδο-αμικου οξεος υδατικης βασεως | |
EP1783126A3 (de) | N-Oxide von N-Phenyl-2-Pyrimidinamin Derivaten | |
EP1734041A3 (de) | Platelet adp rezeptor inhibitoren | |
HK1072181A1 (en) | Pharmaceutical compositions for the oral administration of heparin or derivatives thereof | |
DE50004334D1 (de) | Desodoriende zubereitungen enthaltend wasserlösliche -(1,3)-glucane | |
ATE363267T1 (de) | Mittel zur verbesserung der hauttextur | |
DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
AU5879798A (en) | Agents inhibiting progress of pterygium and postoperative recurrence of the same | |
DK1352658T3 (da) | Forebyggelse eller lægemiddel mod endometriose | |
MXPA05014143A (es) | Derivados de cumarina para el tratamiento de trastornos oftalmicos. | |
HU0102987D0 (en) | Pharmaceutical composition for treating parkinson's disease comprising astrocyte function-improving agent as active ingredient | |
BG106407A (en) | Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof | |
WO2004048381A3 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
EA200600998A1 (ru) | Фармацевтическая композиция, содержащая цинк-гиалуронановый комплекс, предназначенная для лечения рассеянного склероза | |
SE9902674D0 (sv) | New composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |